Therapeutic vaccines in cancer: moving from immunomonitoring to immunoguiding

被引：26

作者：

van der Burg, Sjoerd H. ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2300 RC Leiden, Netherlands

来源：

EXPERT REVIEW OF VACCINES | 2008年 / 7卷 / 01期

关键词：

D O I：

10.1586/14760584.7.1.1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1 / 5

页数：5

共 66 条

[1] Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma [J].

Agarwal, A ;

Rani, M ;

Saha, GK ;

Valarmathi, TM ;

Bahadur, S ;

Mohanti, BK ;

Das, SN .

IMMUNOLOGICAL INVESTIGATIONS, 2003, 32 (1-2) :17-30

[2] Phenotypic analysis of antigen-specific T lymphocytes [J].

Altman, JD ;

Moss, PAH ;

Goulder, PJR ;

Barouch, DH ;

McHeyzerWilliams, MG ;

Bell, JI ;

McMichael, AJ ;

Davis, MM .

SCIENCE, 1996, 274 (5284) :94-96

[3] FLOW CYTOMETRIC DETERMINATION OF CYTOKINES IN ACTIVATED MURINE T-HELPER LYMPHOCYTES - EXPRESSION OF INTERLEUKIN-10 IN INTERFERON-GAMMA AND IN INTERLEUKIN-4-EXPRESSING CELLS [J].

ASSENMACHER, M ;

SCHMITZ, J ;

RADBRUCH, A .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (05) :1097-1101

[4]

Baldwin PJ, 2003, CLIN CANCER RES, V9, P5205

[5] Toward the harmonization of immune monitoring in clinical trials: Quo vadis? [J].

Britten, C. M. ;

Janetzki, S. ;

van der Burg, S. H. ;

Gouttefangeas, C. ;

Hoos, A. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (03) :285-288

[6]

BRITTEN CM, 2007, CANC IMMUNOL IMMUNOT

[7] CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-γ-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination [J].

Casares, N ;

Arribillaga, L ;

Sarobe, P ;

Dotor, J ;

de Cerio, ALD ;

Melero, I ;

Prieto, J ;

Borrás-Cuesta, F ;

Lasarte, JJ .

JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5931-5939

[8] Vaccination for treatment and prevention of cancer in animal models [J].

Cavallo, F ;

Offringa, R ;

van der Burg, SH ;

Forni, G ;

Melief, CJM .

ADVANCES IN IMMUNOLOGY, VOL 90: CANCER IMMUNOTHERAPY, 2006, 90 :175-213

[9] Definition of an immunologic response using the major histocompatibility complex tetramer and enzyme-linked immunospot assays [J].

Comin-Anduix, B ;

Gualberto, A ;

Glaspy, JA ;

Seja, E ;

Ontiveros, M ;

Reardon, DL ;

Renteria, R ;

Englahner, B ;

Economou, JS ;

Gomez-Navarro, J ;

Ribas, A .

CLINICAL CANCER RESEARCH, 2006, 12 (01) :107-116

[10] Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials [J].

Cox, JH ;

Ferrari, G ;

Kalams, SA ;

Lopaczynski, W ;

Oden, N ;

D'Souza, MP .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (01) :68-81

← 1 2 3 4 5 6 7 →